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ABSTRACT 
 
 The role of speech-language pathologists (SLPs) in the assessment and treatment 
of dysphagia in individuals living with HIV/AIDS is relatively absent from the literature. 
Dysphagia is described as difficulty swallowing that can be caused by oral indicators, 
structural dysfunction, and neurological disease (Bladon & Ross, 2007; Bobba et al., 
2007; Nkuize et al., 2010). Dysphagia is a prevalent symptom secondary to the HIV/AIDS 
virus, yet dysphagia in the HIV/AIDS population often goes untreated (Bladon & Ross, 
2007). One way to improve assessment and treatment of dysphagia is to ensure medical 
professionals are knowledgeable of the communication and swallowing disorders that 
can occur in this population. There is an increasing demand for the professional services 
of SLPs in the clinical assessment and treatment of individuals with dysphagia secondary 
to HIV/AIDS.  
 A survey design for the current study examined trends, attitudes, and opinions of 
individuals living with HIV/AIDS by studying a sample of that population (Creswell, 
2009). The design allowed a web-based survey to be available to individuals living with 
HIV/AIDS while maintaining anonymity of the participants. 
  Twenty-one individuals living with HIV/AIDS responded to this survey. All 
participants reported experiencing at least one symptom related to dysphagia. Eight 
participants indicated receiving services from an SLP for dysphagia symptoms. Overall, 
results from the current study suggest SLPs are not involved in the care of individuals 
with dysphagia symptoms secondary to HIV/AIDS. 
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Chapter 1 
Introduction 
 In the United States, over one million people are living with the human 
immunodeficiency virus (HIV), and 20% of those living with HIV are unaware of their 
infection ("HIV/AIDS 101," 2012). The use of highly active antiretroviral treatment 
(HAART) has enabled individuals with HIV and acquired immunodeficiency syndrome 
(AIDS) to live longer with the infection. Consequences of increased survival rate are 
evident in the additional symptoms experienced by people living with HIV/AIDS 
(Anthony & Bell, 2008; Bladon & Ross, 2007; Halvorsen, Moelleken & Kearney, 2003; 
Karus, Raveis, Alexander, Hanna, Selwyn, Marconi, & Higginson, 2005; Nath, Schiess, 
Venkatesan, Rumbaugh, Sacktor, & McArthur, 2008; Nkuize, Wit, Muls, Arvanitakis, & 
Buset, 2010).  
 Potential symptoms affecting the quality of life of individuals living with 
HIV/AIDS could include opportunistic infections, hepatitis, tuberculosis, oral health 
issues, cancer, cardiovascular health problems, diabetes, kidney disease, and dementia 
("HIV/AIDS 101," 2012). A secondary symptom of oral health issues, cancer, and 
dementia is swallowing dysfunction, clinically titled “dysphagia” (Anteyi, Thacher, 
Yohanna, & Idoko, 2003; Halvorsen et al., 2003; Kallail, Downs, & Scherz, 2008; McCabe, 
Sheard, & Code, 2008; McNeilly, 2005; Nkuize et al., 2010; Vasquez, 2000; Swanoepoel 
& Louw, 2010). 
 Dysphagia is one symptom that can have a negative impact on the quality of life 
of HIV/AIDS patients. Oral lesions, structural dysfunction of the swallowing mechanism, 
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neurological disease, and neurological infection can cause dysphagia (Anteyi, Thacher, 
Yohanna, & Idoko, 2003; Halvorsen et al., 2003; Kallail, Downs, & Scherz, 2008; McCabe, 
Sheard, & Code, 2008; McNeilly, 2005; Nkuize et al., 2010; Vasquez, 2000; Swanoepoel 
& Louw, 2010). People living with HIV/AIDS who report swallowing difficulty often do 
not receive sufficient treatment or intervention for the symptom (Bobba, El-Dika, & 
Arsura, 2007; Karus et al. 2005; McNeilly, 2005). Due to the increase of additional 
pathologies in this population, the assessment and treatment of these individuals by a 
speech-language pathologist is vital (Bladon & Ross, 2007; Halvorsen et al., 2003). 
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Chapter 2 
Literature Review 
HIV 
 HIV is a virus that can only infect humans and weakens the immune system by 
destroying cells that function to fight disease and infection (McNeilly, 2005). During the 
first stage of HIV, labeled acute infection, large amounts of the virus are produced in the 
body. In the second stage, clinical latency, HIV reproduces at very low levels but is still 
active. Acquired immunodeficiency syndrome (AIDS) is the last and most severe stage of 
HIV ("HIV/AIDS 101," 2012). HIV infection can result in damage to the central nervous 
system (CNS) and the peripheral nervous system (PNS) (Anthony & Bell, 2008; Mathew 
& Bhat, 2007). Due to the damage of the CNS and/or PNS, and vulnerability to other 
opportunistic and infectious diseases, people living with HIV/AIDS often present with 
additional symptoms separate from the HIV/AIDS infection. Of these symptoms, 
pathologies related to communication and swallowing disorder can occur. Related 
pathologies include, but are not limited to dysphagia, odynophagia, xerostomia, 
neurocognitive disorder, neurological disease and infection, oral lesions, voice disorders, 
hearing loss, and language disorders (Bladon & Ross, 2007; Halvorsen et al., 2003; 
Matthew & Bhat, 2007; McCabe et al., 2008; McNeilly, 2005; Nath et al., 2008). 
 Use of HAART to Treat HIV. Currently, there is no single drug or treatment that 
can cure HIV/AIDS.  Many individuals living with HIV/AIDS take antiretroviral treatments. 
When three or more antiretroviral treatments are taken in combination, it is referred to 
as highly active retroviral treatment (HAART) ("HIV/AIDS 101”, 2012).  The years before 
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HAART was introduced are referred to as the pre-HAART era. Conversely, the years after 
HAART are labeled the HAART or post-HAART era. While additional pathologies were 
more commonly observed in AIDS patients in the pre-HAART era, comorbidities are 
becoming more common in people living with HIV in the HAART era (Anthony & Bell, 
2008). 
 In the era of HAART, the survival rate of people with HIV has increased. This 
treatment has also slowed the development of HIV into AIDS, increasing the amount of 
time from stage 1 to the final stage of AIDS (Bladon & Ross, 2007; Karus et al., 2005). 
Due to the complex nature of the disease, there are many variables that can cause 
additional symptoms in patients with HIV. Some variables are, but not limited to, the 
HIV infection itself, prescribed medications, damage to the CNS and/or PNS, and 
suppression of the immune system (Anthony & Bell, 2008; Bladon & Ross, 2007; Nkuize 
et al., 2010; Robinson-Papp et al., 2008). Although the progression of the disease is 
taking longer with the advent of HAART, individuals continue to experience 
comorbidities secondary to HIV/AIDS that impact functioning in day-to-day life. 
Dysphagia and HIV/AIDS 
 Using a one-to-one-semi-structured interview schedule regarding swallowing 
symptoms, Bladon and Ross (2007) interviewed 120 adults with HIV. Part of the 
interview schedule included a chart of 27 swallowing symptoms. Bladon and Ross 
reported that 79.2% of participants in the study were experiencing at least one 
symptom within the interview schedule. The most commonly reported symptoms were 
dry mouth, pain on swallowing, and difficulty swallowing. Conclusions of the study 
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revealed that dysphagia, odynophagia, and xerostomia (dry mouth) are frequent 
comorbidities experienced by individuals living with HIV/AIDS.  What the researchers did 
not report were the degree and types of treatment provided to the individuals with 
swallowing complaints. 
 Dysphagia is a prevalent symptom secondary to the HIV/AIDS virus. Dysphagia is 
described as difficulty swallowing and can be caused by oral indicators, structural 
dysfunction, and neurological disease (Bladon & Ross, 2007; Bobba et al., 2007; Nkuize 
et al., 2010).  Odynophagia is an additional symptom reported by people living with 
HIV/AIDS. It is painful swallowing that can become severe enough to create a fear of 
eating. Patients experiencing odynophagia also report a lack of salivary secretions 
causing xerostomia. Xerostomia can lead to reduced sensation of the oral cavity, 
reduced bolus transport in the oral and pharyngeal cavities, decreased ability to chew, 
and reduced sensation of the oral cavity (Bladon & Ross, 2007; McNeilly, 2005; Swigert, 
2007).  
 Oral indicators often found in individuals living with HIV/AIDS include oral 
candidiasis, a yeast like infection of the mouth and esophagus, and esophagitis, a fungal 
infection (Nkuize et al., 2010; Swanoepoel & Louw, 2010). These conditions can result in 
painful swallows in multiple phases and during bolus manipulation in the oral phase of 
the swallow. Neurological disease and infection are also commonly associated with a 
diagnosis of HIV/AIDS, and can impede the ability to swallow. Neurological 
manifestations found in individuals living with HIV/AIDS include HIV/AIDS associated 
dementia, HIV encephalopathy, and progressive multifocal leukoencephalopathy (PML) 
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(Anthony & Bell, 2008; Halvorsen et al., 2003; Kallail et al., 2008; Nath et al., 2008; 
Robinson, Byrd, Mindt, Oden, Simpson, & Morgello, 2008; Swanoepoel & Louw, 2010). 
Impaired cognitive functioning resulting from neurological manifestations can result in 
decreased memory, muscle strength, and motor planning or execution. These factors 
can cause abnormal or inefficient swallowing in individuals living with HIV/AIDS.   
 Dysphagia and Effects on Quality of Life (QOL). The World Health Organization 
defines quality of life (QOL) as a person’s overall well being in relation to physical health, 
psychological health, social relationships, and the environment (World Health 
Organization [WHO], 2014). QOL is a unique and multidimensional measure because it is 
reliant on the perception of each individual. Health-related quality of life (HRQOL) is an 
additional measure of aspects that affect either mental or physical health. HRQOL is 
measured based upon an individual’s perceptions of physical and mental health 
including health risks and conditions, functional status, social support, and 
socioeconomic status (Center for Chronic Disease Prevention and Health Promotion, 
2011). The International Classification of Functioning, Disability and Health framework 
(ICF) outlines the dynamic interaction between dysphagia and contextual factors. These 
factors include body functions and structures, activities, participation, personal factors, 
and environmental factors (Bladon & Ross, 2007). Contextual factors in the ICF serve as 
an indication to how dysphagia can cause adverse effect on the measure of QOL an 
HRQOL. Examples of the negative impact caused by the factors of the ICF include a 
decrease in nutritional intake, weight loss, risk for various infections, neurological 
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disease, inability to partake in meals, modified/alternative feeding, and oral 
manifestations (Davis, 2008).   
 Using a symptom scale, Karus et al. (2005) interviewed 376 patients with 
HIV/AIDS at clinics in Alabama, Baltimore, and New York City. They found that at least 
188 (50%) of the participants reported 12 negative health symptoms, one being 
difficulty swallowing. In addition, it was reported that 40-74% of the participants 
interviewed reported having eight negative health symptoms, one being dry mouth. The 
participants described these symptoms as highly frequent, severe, and distressing (Karus 
et al., 2005). According to the ICF, HIV/AIDS related swallowing difficulty is a health 
condition that can lead to body function and structures including oral, pharyngeal, and 
esophageal structures, opportunistic infections, and related medical pathologies. The 
impact of this health condition, when left untreated, can have a negative effect on the 
quality of life of persons with living HIV/AIDS (Bladon & Ross, 2007).  
 When dysfunction in swallowing occurs individuals are at risk for aspiration or 
penetration that result in compromise of their respiratory status. Halvorsen et al. (2003) 
defined aspiration as “leakage below the vocal cords”, and penetration as “leakage into 
the trachea above the level of the vocal cords” (pg. 245). Penetration and aspiration of a 
bolus increases the risk of acquiring an infection in the lungs such as pneumonia. 
Halvorsen and colleagues reported that 8 of 17 patients with HIV/AIDS were found to 
aspirate when presented food boluses by mouth. Of the 8 patients who were aspirating, 
videofluoroscopy revealed signs of aspiration pneumonia. All patients who exhibited 
signs of aspiration were later placed on a modified diet either receiving IV feed or tube 
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feeding. Aspiration pneumonia in individuals living with HIV/AIDS may be detrimental to 
HRQOL because of the patient’s decreased ability to fight disease or infection as well as 
increased likelihood for hospitalization.  
 In the era of HAART, HIV associated weight loss and wasting is still common in 
individuals living with the disease (Jacobsen, Bica, Knox, Wanke, Tchetgen, Spiegelman, 
Silva, 2003). Jacobsen and colleagues periodically interviewed 415 participants with 
HIV/AIDS via telephone to study associations between acute weight loss and related 
symptoms. Results indicated that participants’ risk for acute weight loss increased when 
trouble swallowing and oral symptoms were reported. The authors concluded 
monitoring symptoms that predict weight loss is essential to reduce adverse effects on 
quality of life. When doctors and health professionals are aware of risk factors, like 
trouble swallowing and oral symptoms, management or treatment can be provided to 
decrease the chances of weight loss. The ICF outlines HIV/AIDS related weight loss as an 
activity that can lead to a decrease in participation such as not wanting to eat with 
others or not wanting to eat in public (Bladon & Ross, 2007). QOL is impacted when 
activities and participation of daily living are decreased due to a health condition.  
 Dysphagia and Structural Manifestations. Dysphagia can be caused by the 
dysfunction of the physical structures involved in the four phases of swallowing. 
Dysfunction of the swallowing mechanism can occur at any individual phase of 
swallowing, or in combination. For example, oral infections can affect the ability to 
swallow during the initial (oral preparatory) stages of mastication. It has been estimated 
that 80-90% of individuals living with HIV/AIDS will present with oral candidiasis, an 
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often painful infection, at some point during their illness. Untreated oral candidiasis in 
individuals living with HIV/AIDS can lead to the reduction of food and liquid intake 
because the individuals avoid the discomfort of eating or swallowing (Vasquez, 2000). 
The variety of dysphagia conditions is as varied as the individuals living with HIV/AIDS. 
Some individuals with HIV/AIDS may experience painful swallowing secondary to oral 
infections, while others experience dysfunction of the swallowing mechanism itself 
(Anteyi et al., 2003; Halvorsen et al., 2003; Nkuize et al., 2010; Vasquez, 2000; 
Swanoepoel & Louw, 2010).   
 In a study by Halvorsen et al. (2003), 17 patients with HIV/AIDS who reported 
dysphagia or odynophagia were evaluated through the use of videofluoroscopy. All 
participants exhibited abnormalities in the oral, pharyngeal, and esophageal phases of 
swallowing. These abnormalities included difficulty manipulating and transporting a 
bolus to the back of the mouth, poor forward and backward tongue motion, delayed 
pharyngeal swallow, decreased laryngeal elevation, pooling in the valleculae and 
pyriform sinus, esophageal dysmotility, penetration, and aspiration (Halvorsen et al., 
2003). The authors additionally reported that oral infections such as esophagitis were 
noted in four of the 17 participants examined. A significant finding of this study 
documented that swallowing dysfunction can occur separate from infectious 
involvement. This finding revealed that dysfunction of the swallowing mechanism itself 
caused dysphagia and odynophagia in the majority of the participants (Halvorsen et al., 
2003).  
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 Individuals living with HIV/AIDS are also susceptible to various infections that can 
manifest in the oral cavity and throat. Nkuize and colleagues (2010) conducted a review 
of 706 patients with HIV who underwent upper gastrointestinal endoscopy. The 
participants were divided into three groups labeled pre-HAART (1991-1994), early 
HAART (1999-2002), and recent HAART (2005-2008). They observed the fungal infection, 
candida oesophagitis, in 16 – 23% of the participants. Reflux symptoms reportedly 
increased in the early HAART and recent HAART groups. The authors suggested that 
many patients with HIV/AIDS would likely present with upper gastrointestinal symptoms 
during the course of their disease. Furthermore, the reflux symptoms and oral lesions 
could lead to dysphagia or odynophagia.  
 Similarly, Anteyi et al. (2003) examined 500 patients living with HIV to describe 
the prevalence of oral lesions through the use of structured interview and oral/perioral 
examinations. The authors reported 53% (266 participants) presented with oral lesions. 
While the oral candidiasis lesions were the highest frequency, other prevalent lesions 
included oral ulcerations, hairy leukoplakia, and oral Kaposi’s sarcoma. The high 
prevalence of oral lesions in these individuals living with HIV/AIDS is important. Oral 
lesions are commonly associated the inability to eat or swallow which would further 
compromise the health status of individuals with HIV/AIDS (Anteyi et al., 2003). 
 Dysphagia and Neurological Disease. It is estimated that HIV/AIDS associated 
dementia affects 10 – 20 percent of people living with HIV/AIDS (Anthony & Bell, 2008).  
HIV/AIDS associated dementia is a neurocognitive disorder that is caused by the HIV 
infection (Kallail et al., 2008; McCabe et al., 2008). The HIV infection enters the blood 
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stream and is then circulated throughout the central nervous system.  HIV/AIDS 
associated dementia can cause impairment of neurocognitive functions that most often 
result in executive, motor and memory deficits (Kallail et al., 2008).  
 In addition to HIV/AIDS associated dementia, a number of neurological diseases 
and infections can occur in individuals with HIV/AIDS.  Opportunistic infections found in 
the brain of individuals living with HIV/AIDS include cytomegalovirus, herpes simplex 
virus, and the Epstein Barr virus (McNeilly, 2005). CNS toxoplasmosis, CNS lymphomas, 
and HIV encephalopathy are included in neurologic diseases commonly found in 
individuals living with HIV/AIDS. After computed tomography (CT) and magnetic 
resonance imaging (MRI), Halvorsen et al. (2003) found that 4 of 9 patients presented 
with neurologic infections and diseases. Four patients exhibited abnormal swallowing 
secondary to the neurological condition. When individuals living with HIV/AIDS 
experience secondary neurologic conditions, deficits related to executive functioning, 
motor programming, and memory can be experienced.  
 Memory deficits are some of the initial symptoms that are observed in patients 
with HIV/AIDS associated dementia (Nath et al., 2008). The damage caused by the 
circulation of HIV infected cerebrospinal fluid (CSF) is what often leads to memory 
deficits (Anthony & Bell, 2008). Using MRI, Nath et al. observed that HIV infected CSF 
caused atrophy within different regions of the brain. In particular, lesions appearing in 
the cerebral cortex contribute to memory deficits in individuals with HIV/AIDS 
associated dementia.  When an individual experiences memory deficits, ability to 
swallow can be greatly affected secondary to decreased oral sensation, awareness of 
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environment, and awareness of actions. As HIV/AIDS associated dementia progresses, 
so do the communicative disorders that coexist with the disease.  Memory deficits 
compounded by communication disorders (e.g., perseverating on a topic or decline in 
sentence structure) add complexity to the already failing health condition of the 
individual with HIV/AIDS.  For example, individuals may require prompts to complete a 
meal, not be able to recall whether they have eaten that day, or fail to recognize the 
steps to preparing a meal.  Communication deficits may impede their ability to 
communicate their wants and needs such as thirst, hunger, or discomfort when eating 
as well as physiological dysphagia symptoms. 
 HIV/AIDS associated dementia can also cause impairment in the motor function 
abilities of people living with the infection.  Neuroimaging of patients with HIV/AIDS 
associated dementia reveals a reduction in white matter and grey matter in the basal 
ganglia (Anthony & Bell, 2008).  The primary function of the basal ganglia is to regulate 
motor movement.  The observed neuronal loss in this region, caused by the HIV/AIDS 
associated dementia, is what leads to deficits in motor function. Swallowing is 
predominately not under volitional motor control.  Dysphagia can be present when 
there is a loss or delay in the message to the muscles or bodily structures involved in the 
phases of swallowing.   
 In a study by Robinson-Papp et al. (2008), the motor function of individuals with 
neurocognitive diseases was assessed. The participants included individuals with 
HIV/AIDS associated dementia.  Overall, the researchers found that approximately 50 
percent of participants presented with mild motor impairment, and 25 percent of 
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participants presented with severe motor impairment.  It was reported that the motor 
impairment of participants with HIV/AIDS associated dementia was worse and most 
severely abnormal compared to other neurocognitive diagnoses (Robinson-Papp et al., 
2008).  Swallowing and feeding require unique fine motor movements that can be 
impacted secondary to neurological disease. These results identified the increased risk 
for individuals with HIV/AIDS to have dysphagia secondary to neurocognitive disease. 
Treatment 
 Although there is an apparent need for the treatment of swallowing disorders 
among the HIV/AIDS population, many individuals with the disease may not receive 
sufficient treatment or therapy for their symptoms. Karus et al. (2005) found that of the 
participants who reported swallowing difficulty, only half received treatment. In 
addition, Bladon and Ross (2007) reported that only 33.7% of their participants who 
reported swallowing difficulties received treatment. While some individuals with 
HIV/AIDS do not receive treatment for their swallowing difficulties, those who do may 
not receive appropriate treatment. Medical treatment is used to attempt to treat 
swallowing difficulties, but often individuals do not have access to alternative resources 
such as a speech-language pathologist (Bladon & Ross, 2007). Evaluating, diagnosing, 
and managing dysphagia can be achieved through a team approach. Speech-language 
pathologists have expertise in diagnosing and treating dysphagia. When team members 
are educated with regard to the roles of other professionals, collaborative problem 
solving and referral can take place (Swigert, 2007). For example, if a patient with 
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HIV/AIDS is experiencing dysphagia, a team member could refer the patient for further 
evaluation by a speech-language pathologist.  
Involvement of Speech-Language Pathologists in HIV/AIDS Related Dysphagia 
 A speech-language pathologist can provide professional expertise in the 
assessment and treatment of swallowing disorders (Ad Hoc Committee on the Scope of 
Practice in Speech-Language Pathology, 2007). Treatment of dysphagia can improve 
medical outcomes and overall quality of life for individuals living with HIV/AIDS 
(Ashford, Logemann, & McCullough, 2004). Through objective measures, a speech-
language pathologist can use instrumental methods to assess an individual’s swallowing. 
Examples of instrumental methods may include a modified barium swallow (M 
BS) and fiberoptic endoscopic evaluation of swallowing (FEES).  Furthermore, speech-
language pathologists can use subjective measures to assess swallowing such as a 
bedside clinical examination or physical examination of the oral and swallowing 
structures (Ashford et al., 2004; Swanoepoel & Louw, 2010; Walker, 2011). A speech-
language pathologist can also provide treatment for swallowing disorders through 
stimulation therapies, dietary management, compensatory strategies, biofeedback 
therapy, and strength and exercise therapies (Swigert, 2007). By administering an 
assessment and treatment plan, speech-language pathologists can decrease hospital 
length of stay, need for nonoral feeding, nutritional problems, and costs related to 
pneumonia associated with aspiration (Ashford et al., 2004).  
 Individuals living with HIV/AIDS can experience a wide range of additional 
symptoms separate from the infection itself. There are many variables involved when 
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trying to determine what is causing swallowing difficulties in HIV/AIDS patients. To help 
better evaluate the symptoms commonly experienced by HIV/AIDS patients, more 
detailed assessment needs to occur (Karus et al., 2005). If symptoms associated with 
swallowing difficulty are better assessed, treatment and management of these issues 
could be tailored to the individual patient (Bobba et al., 2007). One way to improve 
assessment and treatment is to ensure medical professionals and other individuals 
involved in the care of HIV/AIDS patients are knowledgeable of the communication and 
swallowing disorders than can occur in people living with HIV/AIDS (Halvorsen et al., 
2003; McNeilly, 2005). There is an increasing demand for the professional services of 
speech-language pathologists in the clinical assessment and treatment of individuals 
with dysphagia secondary to a diagnosis of HIV/AIDS (Bladon & Ross, 2007). Yet, the role 
of speech-language pathologists in the assessment and treatment of people with 
HIV/AIDS is relatively absent from the literature.   
Purpose 
 The purpose of the current study was to explore the involvement of speech-
language pathologists in the assessment and/or treatment of people living with 
HIV/AIDS. It is reported that people living with HIV/AIDS can suffer from a number of 
swallowing difficulties or disorders, and that sometimes these problems go untreated 
(Bladon & Ross, 2007). Services from speech-language pathologists were examined with 
regard to evaluation and treatment for individuals with HIV/AIDS.  
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Research Questions 
The following study questions were explored:  
 1. What dysphagia symptoms are being experienced by individuals living with 
 HIV/AIDS?  
 2. Are individuals living with HIV/AIDS being assessed or treated by a 
 speech-language pathologist for these dysphagia symptoms?  
 3. If so, what is the scope and degree of the evaluation and treatment performed 
 by a speech-language pathologist? 
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Chapter 3 
Methods 
Design 
 A survey design examined trends, attitudes, and opinions of individuals living 
with HIV/AIDS by studying a sample of that population in the current study. The design 
allowed a web-based survey to be available to individuals living with HIV/AIDS while 
maintaining anonymity of the participants.  
Participants/Recruitment 
 Participants included individuals who were diagnosed with HIV or AIDS. The 
Eastern Kentucky University Institutional Review Board approved this study before it 
was distributed to participants.  Consent to participate in the study was implied since 
participation was voluntary and could be discontinued at any time.  One participant 
refused participation since no monetary compensation for participation was provided. 
 The principal investigator (PI) contacted various AIDS service groups in Illinois, 
Indiana, Kentucky, Ohio, and Washington to distribute the web-based survey in a 
national effort toward data collection.  Service groups were contacted because they 
were more likely to provide support for individuals living with HIV/AIDS who were 
willing to participate in the study. The majority of AIDS service groups contacted were 
national organizations with numerous state chapters. However, most AIDS service 
groups contacted did not respond to the PI.  Because of protected identifiers, it is 
unknown from what geographical region respondents were located.  The service groups 
included, but were not limited to, support groups, public health organizations, religious 
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groups, and health centers. The web link for the survey was distributed by leaders of 
AIDS service groups or obtained through access to public flyers in order to maintain 
anonymity of the participants. Recruitment of participants lasted over a period of six 
months.  
Inclusion Criteria 
 To be included in the study, participants met the following criteria:  (1) 18 years 
or older, (2) diagnosed with a stage of HIV or AIDS (self-reported), and (3) native English 
language speakers.  Participants were excluded if they were under the age of 18 or did 
not have a reported diagnosis of HIV or AIDS.   
Sampling/Sample Size 
 Three sampling paradigms were implemented to obtain a maximum amount of 
responses to the study as possible. The first sampling paradigm used was convenience 
sampling. Convenience sampling occurs when participants are selected because they are 
available (Creswell, 2009). It was a convenience to send the survey to AIDS service 
groups who provide services to individuals living with HIV/AIDS. The second type of 
sampling paradigm was purposive sampling, occurring when participants are handpicked 
because they had special characteristics necessary for the purpose of the study 
(Creswell, 2009). The third type of sampling paradigm used was snowball sampling, 
which occurs when participants recommended study participation to other participants 
in a chain referral method (Creswell, 2009). It was considered likely that participants 
referred other participants to this study.  The sample size contained 21 responses from 
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individuals living with HIV/AIDS who experienced swallowing disorders and/or had been 
assessed or treated by a speech-language pathologist. 
Data Collection/Instrumentation 
 Data were collected by distributing a web link of the survey to AIDS service group 
leaders or through access to public flyers (Appendix A).  The survey contained 14 
categorical variables and three open-ended questions (Appendix B).  Including open-
ended questions allowed participants to expand answers, so they were not restricted to 
a specific response. Open-ended questions also allowed participants to expand yes or no 
responses if not a sufficient response.  
Data Analyses 
  Descriptive analyses included the percentage of participants that experienced 
swallowing difficulty and/or disorder while living with HIV/AIDS, and whether 
participants had been assessed or treated by a speech-language pathologist for 
swallowing difficulties. The order of frequency in which swallowing symptoms occurred 
was calculated from most to least frequent (Table 4.3).  Socioeconomic status (SES) 
formulated by the United States Census Bureau was used to described SES of the 
participants (DeNavas-Walt, Proctor, & Smith, 2013). SES was statistically analyzed in a 
quintile frequency of distribution where values of participant’s personal income were 
divided into five groups of equal frequencies (Appendix C). Analyses of the data 
described the average length of time participants had been living with the infection, 
type of treatment received for the infection, type of swallowing symptoms experienced, 
and the type of swallowing difficulty and/or disorder that was diagnosed.  
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 Open-ended questions were analyzed using a thematic analysis or coding 
process. Coding was used to organize expanded responses into chunks or segments of 
texts. This process abbreviated topics into codes, helping to group similar topics or 
codes together (Appendix D; Creswell, 2009). Prior diagnosis of a swallowing disorder 
was coded to compare responses. Reasons for being assessed and/or treated by a 
speech-language pathologist were chunked into a single category. Another coded 
response included information regarding referral source. Abbreviating this particular 
topic revealed the type of professionals that referred respondents to a speech-language 
pathologist. Lastly, the number of times a respondent received professional services 
from a SLP was analyzed.  
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Chapter 4 
Results 
People living with HIV/AIDS can experience a number of swallowing difficulties 
or disorders, and sometimes these problems go untreated (Bladon & Ross, 2007). The 
purpose of this study was to identify the involvement of speech-language pathologists 
(SLP) in the assessment or treatment of people living with HIV/AIDS. Results from a 17-
question survey were analyzed using descriptive and inferential statistics. 
Demographic Characteristics 
 Demographic data are presented in Table 4.11. There were 21 participants with a 
mean age of 31.9 years (range 22-43). The sample included 12 (57.14%) male and 9 
(42.86%) female participants. A similar distribution of White or Caucasian (n=9) and 
Black or African American participants (n=8) was noted.  The sample also included three 
Hispanic or Latino participants, and one participant who indicated his ethnicity as “Black 
and Hispanic and Latino”.  The majority of participants had earned a college degree and 
reported a mean income within the lowest (1st) quintile.  Ten (46.62%) participants had 
Medicaid, Medicare, or other government issued insurance. The remaining participants 
reported having insurance through work (28.57%), private insurance (14.29%), or no 
insurance (9.52%).  
 Clinical Characteristics. The group mean of time living with HIV/AIDS was 3.83 
years (range 2 months – 10 years). Participants who reported receiving assessment or 
treatment from an SLP (n=8) had been diagnosed longer (m=5.09 years) than 
                                                          
1 All tables containing participant characteristic data can be found in Appendix E 
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participants who had not received assessment or treatment (m=2.30 years). A t-test was 
used to compare groups using an alpha level of .05 for all statistical tests. The difference 
was found to be statistically significant (p=0.04). 
 A Fisher’s test was calculated to examine the relationship between participants’ 
diagnoses (HIV, AIDS) and their intervention group (received SLP services, had not 
received SLP services). The association between intervention groups and diagnosis was 
not statistically significant (p=0.63). Distribution of diagnoses in the sample was 
unequal, with 71% of participants having a diagnosis of HIV and 29% with a diagnosis of 
AIDS (Table 4.2).  
 The most prevalent treatment medication received was Nucleoside/Nucleotide 
Reverse Transcriptase inhibitors (NRTIs), followed by Non-Nucleoside Reverse 
Transcriptase Inhibitors (NNRTIs).  
Dysphagia Symptoms 
 The first research question examined what dysphagia symptoms were 
experienced by individuals living with HIV/AIDS. Data revealed that all 21 participants 
experienced at least one symptom associated with dysphagia, with one participant who 
reported a total of 13 symptoms. Table 4.3 provides the symptom prevalence reported 
by participants. Symptoms reported with the highest frequency included heartburn 
(47.6%), difficulty swallowing (42.9%), difficulty swallowing pills (38.1%), dry mouth 
(33.3%), food catching in the throat (33.3%), and coughing while eating or drinking 
(28.6%). These suggest that symptoms are predominantly pharyngeal and esophageal in 
nature.  One participant reported a symptom that was unlisted and described it as, 
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“feeling food is going down the wrong way and coughing something up.” This would 
imply dysfunction within the pharyngeal and esophageal swallowing phases.  Though 
participants described multiple signs of oropharyngeal and esophageal dysphagia, the 
majority had not received assessment or treatment for dysphagia symptoms.  
 A t-test was used to compare the number of symptoms experienced by 
participants who had received SLP services and those who had not.  Participants who 
reported receiving SLP services (n=8) reported more dysphagia symptoms (m=6) than 
participants who had not received SLP services (n=13; m=2.85 dysphagia symptoms). No 
statistically significant difference was found (p=0.05).  
Speech-Language Pathology Experiences 
 The second question explored whether individuals living with HIV/AIDS were 
being assessed or treated by a SLP for reported dysphagia symptoms. Only 38% (8/21) 
of the participants indicated they had been assessed or treated by a SLP.  One 
participant indicated being assessed or treated for dysphagia symptoms, but was unsure 
whether an SLP was involved with the services provided. Data for participants’ 
diagnosis, average length of diagnosis, mean dysphagia symptoms reported, and referral 
source are presented in Table 4.4.  
 Referred Symptoms. Dysphagia symptoms reported by participants who 
received services from an SLP were compared to the dysphagia symptoms reported by 
participants who did not receive SLP services. Table 4.5 outlines the dysphagia 
symptoms reported in each intervention group.  A Fisher’s test was calculated to 
examine the relationship between reported symptoms and intervention groups 
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(received SLP services or had not receive SLP services).  The only statistically significant 
association was between intervention groups and the reported symptom of heartburn 
(p=0.02). More participants who received SLP services (n=8) reported experiencing 
heartburn (n=7) than participants who had not received SLP services (n=13; n=4 
reported experiencing heartburn).  
Level of Speech-language Pathology Care 
 The third research question examined the scope and degree of services provided 
by a SLP. Eight participants reported speech-language pathology services included in 
their care.  Six of the eight participants reported the degree of services received. 
Overall, the mean number of sessions was 2.33 (range 1-5).  
Treatment Characteristics 
 Seven participants indicated they had been assessed and/or treated by a SLP. 
Five participants reported being formally diagnosed with a swallowing problem or 
disorder. Of those participants, four described the dysphagia as involving a diet change, 
swallowing problem, pain on swallowing, and body weakness. The majority received 
services from an SLP in a hospital setting. Table 4.6 provides data on where SLP services 
were provided. 
 Reasons for referral for SLP assessment or treatment included coughing while 
eating or drinking, difficulty swallowing, pain associated with swallowing, weight loss, 
and problems associated with eating.  These align with the reported symptoms.  In this 
study, the most commonly reported symptoms were heartburn, coughing while eating 
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drinking, coughing or choking during swallowing, specific foods are difficult to swallow, 
difficulty swallowing, food catches in the throat, and infections of the oral cavity.  
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Chapter 5 
Discussion 
 The current study examined the involvement of speech-language pathologists 
(SLP) in the assessment or treatment of individuals living with HIV/AIDS.  A survey was 
administered to participants living with HIV/AIDS in five states.  This chapter includes a 
discussion of results for each research question.  Limitations and conclusions are 
presented following the discussion of questions.  
Review and Discussion of Results 
 To reach individuals living with HIV/AIDS, a survey was distributed to support 
groups, public health organizations, religious groups, and health centers. Twenty-one 
people completed the survey, which implied 21 participants chose to or met the 
requirements to complete the survey. Individuals may not have completed the survey 
for multiple reasons including withdrawing consent, insufficient time to complete the 
survey, lack of access to a computer, or confidentiality reasons. Anecdotally, some 
respondent queries declined participation because there was no monetary payment for 
participation.  Additionally, not including acute care facilities may have limited access to 
potential participants. 
 Low response rate may indicate insufficient methods of survey distribution or 
data collection. Additionally, attempting to contact a protected population of 
participants may have contributed to the low response rate. The survey was confidential 
and did not request protected health information. Yet, perceptions of possible 
association to the distribution of the survey may have left some individuals questioning 
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confidentiality related to participation. For example, if a participant took a tab from the 
recruitment flyer, a passerby could assume the individual had HIV/AIDS and was 
participating in the study. 
Dysphagia Symptoms Experienced by Individuals Living with HIV/AIDS 
 In the present study, all participants had or were currently experiencing at least 
one symptom related to dysphagia. Table 4.3 outlines the frequency of reported 
dysphagia symptoms by all participants. Similar to the results of previous studies 
(Bladon & Ross, 2007; Bobba et al., 2007; Halvorsen et al., 2003; Nkuize et al., 2010; 
Walker, 2011), heartburn, difficulty swallowing, difficulty swallowing pills, dry mouth, 
food catching in the throat, and coughing while eating or drinking were commonly 
experienced by participants. The majority of reported symptoms in this study were 
indications of possible oropharyngeal or esophageal phase dysphagia. These results are 
comparable to other studies with individuals with HIV/AIDS. Halvorsen et al. (2003) and 
Walker (2011) found through instrumental testing that all participants with HIV/AIDS 
demonstrated some dysfunction in at least one phase of swallowing.  This study adds to 
the literature that indicates individuals living with HIV/AIDS are at risk for dysphagia and 
resulting complications.  Nutrition is important to resolution of any disease course 
(Jacobson et al., 2003).  Late stage HIV/AIDS is characterized by acute weight loss and 
fatigue (Anteyi et al., 2003).  Maintaining optimal oral intake and reducing or preventing 
dysphagia symptoms may delay these acute disease effects.     
 Signs or Symptoms of Dysphagia. While all participants experienced at least one 
symptom of dysphagia, individuals who received SLP services reported more symptoms 
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(m=6) compared to individuals who did not receive SLP services (m=2.85).  The 
difference between groups was not statistically significant (p≥.05). Data imply that 
reporting of more symptoms did not relate to receiving SLP services. This is important 
because it indicates type or severity of symptoms are not a determining factor regarding 
participants that received management of their symptoms.  This is counter-intuitive in 
that more disease symptoms typically result in increased services or referrals.  Results in 
the current study do not support this assumption. 
 Incidence of Dysphagia Symptoms. The frequency of each dysphagia symptom 
reported by individuals who received SLP services was compared to the group of 
participants who reported the same symptom, but did not receive SLP services. Data 
revealed that 18 of the 21 reported dysphagia symptoms were experienced by both 
groups of participants (received – did not receive SLP services). Excluding heartburn, it 
was found that the amount of participants who reported the same dysphagia 
symptom(s) between groups was not statistically significant. This suggests that besides 
heartburn, there was not one specific dysphagia symptom that was more likely to lead 
to assessment or treatment by an SLP.  Practitioners may need to take note when 
heartburn (reflux) is reported since it may be predictive of a progression toward more 
involved dysfunction in swallowing. 
 It is unclear how the HIV/AIDS disease course for the respondents receiving SLP 
services influenced complaints.  In a medical setting, patients often describe 
experiencing heartburn, which is a common clinical indication for reflux (these terms are 
often used interchangeably). In the HIV/AIDS population as others, heartburn could 
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appear secondary to irritation from medication or as an independently occurring 
symptom. However, with heartburn as the most frequently reported dysphagia 
symptom, consideration for reflux as a “red flag” to more complex sequelae is an 
important consideration.  Recognition of reflux as potentially leading to more complex 
dysphagia symptoms may enable earlier diagnoses and proactive management for 
individuals with HIV/AIDS.  
Stage of Infection   
 Diagnosis Category. Overall, more individuals with a diagnosis of HIV (n=15) 
responded to the survey. There was no statistically significant difference (p≥.05) 
between diagnoses (HIV – AIDS) and intervention groups (received – did not receive SLP 
services).  This suggests participants with a diagnosis of HIV were not more likely to 
receive services from an SLP than individuals with HIV/AIDS. For this study sample, stage 
of diagnosis was not a predictor of who received SLP services. This suggests that 
complexity of symptoms or disease progress did not result in increased service provision 
for this sample. Any individual living with HIV/AIDS, regardless the stage of diagnosis, 
could be experiencing symptoms of dysphagia that are going untreated.  SLPs involved 
in initial referrals of individuals with HIV/AIDS need to encourage follow up to facilitate 
a continuum of care. 
 Length of Diagnosis. The amount of years living with a diagnosis of HIV/AIDS was 
a statistically significant difference (p≤.05) observed between service groups (received – 
did not receive SLP services). Participants who received services from an SLP had been 
living longer with a diagnosis of HIV/AIDS (m=5.09 years) compared to participants who 
30 
 
did not receive services (m=2.30 years).  When a person is living with a diagnosis such as 
HIV/AIDS for an increased period of time, they may have received more healthcare, 
information about co-morbidities of the infection, help relating to living with HIV/AIDS, 
or experienced dysphagia symptoms for a longer period of time. These factors could 
lead to increased awareness and intervention of dysphagia symptoms.  
Scope and Degree of SLP Evaluation and Treatment 
 While participants in this study experienced similar symptoms of dysphagia, only 
38% reported receiving services from an SLP. These results support previous research.  
Earlier studies have established that only a fraction of individuals with HIV/AIDS who 
reported swallowing difficulty had later received assessment or treatment related to 
dysphagia (Bladon & Ross, 2007; Karus et al., 2005).  SLP services provided during early 
stages of the disease might enable preventive dysphagia measures to be established. 
 Description of Dysphagia Symptoms. The 8 participants who received services 
from a SLP described swallowing problems as coughing while eating or drinking, 
difficulty swallowing, pain associated with swallowing, weight loss, and problems 
associated with eating.  These symptoms of dysphagia and their evaluation or treatment 
appear common to this population (Anteyi et al., 2003; Bladon & Ross, 2007; Jacobson 
et al., 2003; Vazquez, 2000).  These behaviors would likely be disruptive to daily 
participation and engagement during meals.  These dysphagia symptoms might result in 
oral intake avoidance as well as avoidance of social interactions during meals.  This 
could negatively impact quality of life as it relates to common mealtime interactions, 
important to daily interactions within multiple settings.   
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  Dysphagia Diagnosis. Only half of the participants who reported receiving 
services were diagnosed with a swallowing problem. These diagnoses were defined as a 
swallowing problem, pain on swallowing, and body weakness. One participant who 
received a diagnosis was also recommended a diet change. Formally diagnosing 
dysphagia is important in order to identify that separate care of swallowing problems 
needs to be addressed in addition to the infection itself.  A diagnosis of dysphagia would 
need referral to SLP services to provide appropriate specialized care with regards to 
swallowing difficulty. It may also allow for monitoring of swallowing function over time 
to determine if symptoms have increased or worsened (Bladon & Ross, 2007). 
 Referral Source. Five of the eight participants who received services from an SLP 
indicated what type of professional referred them for assessment or treatment. Four 
participants specified that a medical doctor, including a gastroenterologist, made the 
referral to an SLP. One participant stated a physician and SLP worked together to refer 
for assessment or treatment of dysphagia symptoms. The importance that healthcare 
professionals work as a multidisciplinary team to provide appropriate care for 
individuals with HIV/AIDS is known (Karus et al., 2005; McNeilly, 2005).  The fact that 
only half of the referrals were from a medical physician indicates the burden SLP 
professionals continue to face with regard to informing other health professionals about 
their expertise in diagnosing and treating dysphagia.   
 Degree and Frequency of Intervention. The mean number of sessions was 2.33 
(range 1-5) for participants who reported receiving services from an SLP. The 
infrequency with which participants received services suggests that only an assessment 
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of dysphagia was performed. An SLP is often involved in clinical assessment of dysphagia 
to provide diet recommendations for safe oral consumption or treatment strategies (Ad 
Hoc Committee on the Scope of Practice in Speech-Language Pathology, 2007; Bladon & 
Ross, 2007; Swigert, 2007; Walker, 2011). The present study, and previous studies 
(Halvorsen et al., 2003; Jacobson et al., 2003), imply that involving an SLP in care can 
help avoid negative impacts on quality of life such as unintentional weight loss or 
pneumonia secondary to dysphagia.   
Strengths and Limitations 
 The participation of SLPs in the assessment or treatment of individuals with 
dysphagia secondary to HIV/AIDS is relatively absent in the current literature.  This study 
expands the research examining symptoms of dysphagia experienced by individuals with 
HIV/AIDS. It also investigated the scope and degree of SLP services provided to 
individuals living with HIV/AIDS.  
 The present study supports the need for identification and intervention of 
dysphagia symptoms that coincide with a diagnosis of HIV/AIDS. Those who are living 
with HIV/AIDS will be managing symptoms secondary to the infection for the remainder 
of their lives since no cure has been found to date. Dysphagia is one symptom that can 
negatively impact QOL when untreated (Bladon & Ross, 2007).  Involving SLPs in the 
care for individuals who experience dysphagia may help to maintain appropriate and 
safe swallowing for nutritional intake.  Promoting safe and functional swallowing may 
offer support to sustaining health in people living with HIV/AIDS 
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 As with many studies of individuals in vulnerable populations, low participant 
response rate limits generalization of the results and likely influenced the level of 
significant findings. While multiple AIDS service groups were contacted regarding the 
study, it is unknown how many actually distributed or displayed the recruitment poster. 
Additional methods should be considered when attempting to contact a protected 
population of participants. Contacting AIDS service groups over other organizations, 
such as hospitals, provided quicker access to individuals living with HIV/AIDS.  Perhaps, 
comprehensive review of the medical records charts of people with HIV/AIDS or acute 
hospital admissions could provide as much insight into their healthcare history.  
 A survey method of data collection can also limit the depth of responses from 
participants. Responding to close-ended questions through a web-based survey may 
result in limited responses that can be completed quickly and simply from prescribed 
choices. Mixed methods inclusive of qualitative and quantitative methods may allow for 
more clarification and expansion through the addition of more open-ended questions 
and qualitative analyses.  
Conclusions 
 Data from the current study suggest individuals living with HIV/AIDS who receive 
SLP services are experiencing the same or similar reported swallowing symptoms as 
individuals who have not received SLP services. While some participants received SLP 
services, the degree and frequency with which they were provided was limited. It is 
important for SLPs to consider the chronicity of symptoms for the HIV/AIDS population. 
Implementing a health care model similar to the management provided for patients 
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diagnosed with cancer may be beneficial for this population. For example, individuals 
being treated for cancer typically receive services that monitor disease progression over 
time with responsive management to new symptoms whether considered related to the 
original cancer diagnosis or not.  That type of protocol and responsiveness does not 
appear to be the standard of care for individuals living with HIV/AIDS.  Reflux has been 
suggested in this study as a precursor for more complex dysphagia symptoms.  Perhaps, 
too often, reflux is treated as a separate symptom, unrelated to the HIV/AIDS.  
Consideration for screening and monitoring of symptom progression for all individuals 
living with HIV/AIDS may increase care with regard to dysphagia. Within this model, SLPs 
must provide education, assessment, treatment, and recommendations for those who 
are currently, or in the future, experiencing swallowing difficulty. This would allow SLPs 
to monitor swallowing function through follow up consults throughout the course of the 
infection in order to provide necessary, proactive treatment to maintain safe oral 
nutritional intake.  
 The importance of assessment or treatment of dysphagia by an SLP has been 
supported for the HIV/AIDS population (Bladon & Ross, 2007; Halvorsen et al., 2003; 
Jacobson et al., 2003). However, there is still a discrepancy in identifying distinguishing 
factors between participants who received SLP services and participants who did not 
receive SLP services.  Consideration is needed as to whether healthcare professionals 
understand potential negative consequences on quality of life that dysphagia secondary 
to HIV/AIDS can have.  SLPs must provide education to fellow practitioners and other 
health care professionals with regard to dysphagia in the HIV/AIDS population.  In 
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addition, SLPs must advocate for their expertise to be included in the management of 
dysphagia for individuals living with HIV/AIDS.  
Implications 
 The current study suggests SLPs are not consistently involved in the care of 
individuals with HIV/AIDS who report dysphagia symptoms. Furthermore, the degree 
and frequency with which SLP services are being provided to some individuals implies 
that only assessment is provided. If medical professionals and other individuals involved 
in the care of patients with HIV/AIDS are more knowledgeable of the communication 
and/or swallowing disorders related to the infection, they may be more likely to include 
a SLP in the assessment and treatment of these individuals. Including SLPs as team 
members would lead to more effective assessment and treatment of swallowing 
disorders present in individuals with HIV/AIDS (Bladon & Ross, 2007; Halvorsen et al., 
2003; Jacobson et al., 2003; McNeilly, 2005).  SLPs must continually advocate for their 
expertise in providing comprehensive care to individuals living with HIV/AIDS. 
 Moreover, only one participant in the current study reported an incidence of an 
SLP and doctor working together in dysphagia management. Collaborative dysphagia 
management appears lacking.  This suggests an increased need for healthcare 
professionals to work as an interdisciplinary team. Involving SLPs in the care of 
individuals with HIV/AIDS who report symptoms of dysphagia may help reduce or 
eliminate negative effects on quality of life secondary to dysphagia. 
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Future Research 
 Future research regarding the role of SLPs in the assessment or treatment of 
dysphagia in individuals with HIV/AIDS is needed. In addition, examining the impact 
educational level, income, or insurance type have on receipt of SLP services may offer 
further insight into which individuals are obtaining intervention for dysphagia 
symptoms. 
 Identifying specific methods and service delivery models of assessment and 
treatment would provide clarity to the role of the SLP in HIV/AIDS management. The 
current study suggests individuals living with HIV/AIDS are experiencing symptoms of 
dysphagia, but few are receiving appropriate SLP assessment or treatment. More is 
needed to inform the profession with regard to best practice with this vulnerable 
population.   
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Recruitment Flyer 
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APPENDIX B: 
Swallowing Symptom & SLP Intervention Survey 
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1. Please specify your age 
2. Please specify your gender 
a. Male 
b. Female 
c. Other (Please specify below) 
________________________________________________ 
3. Please specify your ethnicity 
a. White or Caucasian 
b. Hispanic or Latino 
c. Black or African American 
d. Native American or American Indian 
e. Asian/Pacific Islander 
f. Other (Please specify below) 
________________________________________________ 
4. What is the highest degree or level of school you have completed? If currently 
enrolled, highest degree received.  
a. No schooling completed 
b. Nursery school to 8th grade 
c. Some high school, no diploma 
d. High school graduate, diploma or the equivalent (GED) 
e. Some college credit, no degree 
f. Trade/technical/vocational training 
g. Associate degree 
h. Bachelor’s degree 
i. Master’s degree 
j. Professional degree 
k. Doctorate degree 
5. What is your total household income? 
a. $0 to $25,999 
b. $26,000 to $47,999 
c. $48,000 to $73,999 
d. $74,000 to $110,999 
e. $111,000 to 183,999 
f. $184,000 or more 
6. What type of insurance do you have? 
a. Medicaid, Medicare, or other government insurance 
b. Health insurance at work 
c. Private (e.g. Cigna) 
d. None 
e. Other (Please specify below) 
________________________________________________ 
7. What is your diagnosis?  
a. Human Immunodeficiency Virus (HIV) Positive 
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b. Acute Infection 
c. Clinical Latency 
d. Acquired Immunodeficiency Syndrome (AIDS) 
e. Other (Please specify below) 
________________________________________________ 
8. How long have you been living with HIV/AIDS? 
9. What type of treatment have you received or are currently receiving? 
a. Multi-Class Combination Drugs (Atripla, Complera, Stribild, Trii) 
b. Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) (Combivir, 
Emtriva, Epivir, Epzicom, Retrovir, Trizivir, Truvada, Videx, Viread, Zerit, 
Ziagen, Amdoxovir, Tenofovir alafenamide fumarate) 
c. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (Edurant, 
Intelence, Rescriptor, Sustiva, Viramune, Lersivirine) 
d. Protease Inhibitors (PIs) (Aptivus, Crixivan, Invirase, Kaletra, Lexiva, Norvir, 
Prezista, Reyataz, Viracept)  
e. Entry/Fusion Inhibitors (Fuzeon, Selzentry, Cenicriviroc, Ibalizumab, PRO 140) 
f. Integrase Inhibitors (Isentress, Tivicay, Elvitegravir) 
g. Pharmacokinetic Enhancers (Norvir, Cobicist, SPI-452) 
h. Immune-Based Therapies (Aralen, DermaVir, Interleukin-7, Lexgenleucel-T, 
Plaquenil, Proleukin, SB-728-T, Vacc-4x) 
i. Holistic/Alternative Therapies (e.g., accupuncture, herbal supplements, etc.) 
j. Other (Please specify below) 
________________________________________________ 
10. Have you ever experienced the following symptoms resulting in swallowing and/or 
eating difficulty? (Select all that apply) 
a. Heartburn 
b. Dry mouth 
c. Changes to the ability to taste 
d. Difficulties with eating 
e. Pain on swallowing 
f. Specific foods that are difficult to swallow 
g. Difficulty swallowing 
h. Burning/tingling sensation in the mouth 
i. Hot food is easier to swallow than cold 
j. Food remaining in the mouth after swallowing 
k. Solids are more difficult than liquids 
l. Cold food is easier to swallow than hot 
m. Difficulty chewing 
n. Excessive saliva or mucus in the mouth 
o. Coughing while eating or drinking 
p. Difficulty swallowing pills 
q. Food catches in the throat 
r. Coughing or choking after swallowing 
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s. Takes a long time to swallow 
t. Choking while eating or drinking 
u. Food comes back up after swallowing 
v. Coughing or choking during swallowing 
w. Drooling 
x. Coughing or choking before swallowing 
y. Liquids are more difficult to swallow 
z. Nasal regurgitation 
aa. Food falling out of the mouth 
bb. Infections of the oral cavity  
cc. Other (Please specify below) 
________________________________________________ 
11. Have you ever been diagnosed with a swallowing problem and/or disorder?  
a. Yes 
b. No 
c. Other (Please specify below) 
________________________________________________ 
12. If you responded yes to #11, please explain the swallowing problem and/or 
disorder with which you were diagnosed: 
13. Have you ever been assessed or treated by a speech-language pathologist? 
a. Yes 
b. No 
c. Other (Please specify below) 
________________________________________________ 
14. If you responded yes to #13, what was the reason for being assessed and/or 
treated by the speech-language pathologist? 
15. If you responded yes to #13, for what length of time/how many sessions were you 
seen by the speech-language pathologist?  
16. If you responded yes to #13, who referred you to be seen by the speech-language 
pathologist? 
17. If you responded yes to #13, in what setting were you seen by the speech-language 
pathologist?  
a. Hospital 
b. Medical Clinic 
c. Speech-Language Hearing Clinic 
d. Other (Please specify below) 
________________________________________________ 
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Appendix  C: 
Personal Income Quintile Frequency 
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Quintile Income Range (n) 
Lowest Quintile 0 - 25, 999 7 
Second Quintile 26, 000 - 47, 999 6 
Middle Quintile 48, 000 - 73, 999 4 
Fourth Quintile  74, 000 - 110, 999 4 
Highest Quintile  111, 000 - 183, 999 0 
Top 5 Percent  184, 000 or more 0 
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Appendix D: 
Thematic Analysis  
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Themes (n) Examples of quotes reflecting theme 
Diagnosed with a 
swallowing 
problem/disorder 
5 
Diet change; Swallowing problem; Pain on 
swallowing; Body weakness 
Assessed/Treated by a 
speech therapist 
7 Not reported  
Reasons for being 
assessed/treated by a 
speech therapist 
7 
Coughing while eating/drinking; Difficulty 
swallowing; Pain associated with swallowing; Weight 
loss; Problems associated with eating 
Amount of 
assessment/treatment 
8  2.33 (range 1-5) 
Referral source 6  Doctor; Gastroenterologist; Unknown 
Location of 
assessment/treatment 
8 Hospital; Medical Clinic 
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Appendix E: 
Participant Characteristic Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 
 
 
Table 4.1 
Demographic Characteristics for Participants (N = 21) 
 
Demographic Characteristic Percent (n) 
Age, mean years                           M=31.9                               
Gender   
Male 57.14 12 
Female 42.86 9 
Ethnicity   
White or Caucasian 42.86 9 
Hispanic or Latino 14.29 3 
Black or African American 38.1 8 
Other 4.76 1 
Educational Level   
High school graduate, diploma or GED 14.29 3 
Some college credit, no degree 14.29 3 
Trade/technical/vocational training 14.29 3 
Associate degree 14.29 3 
Bachelor's degree 33.33 7 
Master's degree 9.52 2 
Personal Income   
$0 to $25,999 33.33 7 
$26,000 to $47,999 28.57 6 
$48,000 to $73,999 19.05 4 
$74,000 to $110,999 19.05 4 
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Table 4.2 
Clinical Category, Medication, and Length of Diagnosis for Participants (N=21) 
 
Clinical Characteristic Percent (n) 
Length of Diagnosis, mean years              M=3.83     
Diagnosis     
HIV 71.43 15 
AIDS 28.57 6 
Treatment Medication     
Multi-Class Combination Drugs  23.81 5 
NRTIs 90.48 19 
NNRTIs 76.19 16 
Protease Inhibitors (PIs)  42.86 9 
Entry/Fusion Inhibitors 38.1 8 
Integrase Inhibitors 4.76 1 
Pharmacokinetic Enhancers  14.29 3 
Immune-Based Therapies 33.33 7 
Holistic/Alternative Therapies 19.05 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
 
 
Table 4.3 
Percentage of Participants in Each Symptom Category 
 
Variable Percent (n) 
Symptom   
Heartburn 47.6 10 
Difficulty swallowing 42.9 9 
Difficulty swallowing pills 38.1 8 
Dry mouth 33.3 7 
Food catches in the throat 33.3 7 
Coughing while eating or drinking 28.6 6 
Difficulties with eating 23.8 5 
Burning/tingling sensation in the mouth 23.8 5 
Pain on swallowing 19.0 4 
Coughing or choking during swallowing 19.0 4 
Specific foods that are difficult to swallow 14.3 3 
Infections of the oral cavity  14.3 3 
Hot food is easier to swallow than cold 9.5 2 
Difficulty chewing 9.5 2 
Changes to the ability to taste 9.5 2 
Food remaining in the mouth after swallowing 4.8 1 
Solids are more difficult than liquids 4.8 1 
Cold food is easier to swallow than hot 4.8 1 
Coughing or choking after swallowing 4.8 1 
Takes a long time to swallow 4.8 1 
Choking while eating or drinking 4.8 1 
Other (please specify) 4.8 1 
Excessive saliva or mucus in the mouth 0 0 
Food comes back up after swallowing 0 0 
Drooling 0 0 
Coughing or choking before swallowing 0 0 
Liquids are more difficult to swallow 0 0 
Nasal regurgitation (food coming out the nose) 0 0 
Food falling out of the mouth 0 0 
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Table 4.4 
Participants Who Reported Speech-Language Pathology Services (n=8)  
 
Participant Diagnosis 
Length of 
Diagnosis (years) 
# of 
Dysphagia 
Symptoms 
Referral Source 
P1 AIDS 7 5 not reported 
P2 AIDS 6 8 not reported 
P3 AIDS 10 13 Doctor 
P4 HIV* 5.25 6 not reported 
P5 HIV* 2.5 2 Gastroenterologist 
P6 HIV* 3 3 Doctor 
P7 HIV* 4 5 Doctor 
P8 HIV* 3 5 Doctor (working w/ SLP) 
Mean   5.09 9.25   
 
Note: = Acquired Immunodeficiency Syndrome (AIDS), * = Human Immunodeficiency Virus 
(HIV) 
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Table 4.5  
Dysphagia Symptoms Reported by Intervention Groups 
 
Dysphagia Symptom 
Reported 
Intervention by 
SLP 
No Reported 
Intervention 
by SLP 
p Value 
Heartburn 7 4 0.02* 
Difficulty swallowing 6 4 0.08 
Difficulty swallowing pills 3 4 1 
Dry mouth 2 2 0.62 
Food catches in the throat 3 4 1 
Coughing while eating or drinking 4 3 0.35 
Difficulties with eating 3 2 0.33 
Burning/tingling sensation in the mouth 2 3 1 
Pain on swallowing 3 1 0.25 
Coughing or choking during swallowing 3 1 0.25 
Specific foods that are difficult to swallow 2 1 0.53 
Infections of the oral cavity  2 1 0.53 
Hot food is easier to swallow than cold 1 1 1 
Difficulty chewing 1 1 1 
Changes to the ability to taste 2 0 0.13 
Food remaining in the mouth after swallowing 1 0 0.38 
Solids are more difficult than liquids 0 1 1 
Cold food is easier to swallow than hot 0 1 1 
Coughing or choking after swallowing 0 1 1 
Takes a long time to swallow 1 0 0.38 
Other (please specify) 0 1 1 
 
Note: * = statistical significance 
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Table 4.6  
Treatment Location Percentage Reported by Participants (N=21) 
 
Treatment Location Percent (n) 
Hospital 87.5 7 
Medical Clinic 12.5 1 
Speech-Language Hearing Clinic 0 0 
Home-health  0 0 
 
